AUS
NZ
UK
CA
USA
IND
Pharma
Can Neuren Pharmaceuticals Align with ASX Healthcare Sector Metrics?
May 17, 2025 10:32 AM AEST| By Team Kalkine MediaCan Neuren Pharmaceuticals Align with ASX Healthcare Sector Metrics?
Can ASX Tech Micro-Caps Sustain Momentum Amid Cash Burn Pressures on the ASX All Ordinaries?
May 11, 2025 04:30 PM AEST| By Team Kalkine MediaCan ASX Tech Micro-Caps Sustain Momentum Amid Cash Burn Pressures on the ASX All Ordinaries?
How Is Nyrada Inc. Performing in the ASX Health Sector?
May 08, 2025 02:32 PM AEST| By Team Kalkine MediaHow Is Nyrada Inc. Performing in the ASX Health Sector?
What Are the Key Growth Drivers for Channel Infrastructure NZ (ASX:CHI)?
June 18, 2026 03:21 PM AEST| By Sonal GoyalChannel Infrastructure NZ (ASX:CHI) is an energy infrastructure business that stepped onto the Australian Securities Exchange on 19 December 2025, bringing a substantial fuel and energy infrastructure operation onto the radar of Australian investors. With a market capitalisation of around $1.06 billion, Channel Infrastructure …
Emyria Limited (ASX:EMD) Share Activity Reviewed Amid ASX 200 and Health Sector Focus
May 06, 2025 02:31 PM AEST| By Team Kalkine MediaHighlights,Emyria Limited shares experienced notable upward movement in recent sessions,Company insiders reported significant equity interest over the past year,Trading records show higher share acquisitions than disposals overall,Emyria Limited (ASX...
Key Insider Activity at Althea Group Holdings (ASX:AGH) – Insight on Recent Developments
May 03, 2025 02:34 PM AEST| By Team Kalkine MediaHighlights:,CEO Joshua Fegan made a significant stock purchase in Althea Group Holdings (ASX:AGH).,Over the last year, the company experienced a net buying trend in insider transactions.,Despite strong insider alignment, there are notable concerns re...
Island Pharmaceuticals ASX:ILA Transactions: Ownership and Share Trends Reviewed | ASX All Ordinaries & ASX 200
May 02, 2025 02:35 PM AEST| By Team Kalkine MediaHighlights,Market capitalization increased significantly for Island Pharmaceuticals (ASX:ILA) during the year,Company insiders showed more buying activity than selling over the review period,Ownership by company insiders remains a substantial portion...
ASX: DXB — Dimerix Lands Asian Licensing Deal Worth Up to $480m as Kidney Drug Story Expands
June 18, 2026 02:09 PM AEST| By Aditi SarkarHighlightsDimerix (ASX: DXB) has reported a regional licensing deal in Asia worth up to $480 million, expanding the commercial story around its kidney disease programme.Licensing deals of this kind typically involve upfront and milestone-based components, with the headline figure representing the maximum potential value …
Can This ASX Healthcare Stock Sustain Its Momentum on the S&P/ASX 200 and All Ordinaries Indexes?
April 19, 2025 08:30 AM AEST| By Team Kalkine MediaHighlights,The company operates in the healthcare sector and is listed on both the S&P/ASX 200 and All Ordinaries indexes.,Cash expenditure has declined, enhancing its ability to maintain operations over the medium term.,Revenue growth has coincided...
The Share Price of Althea Group Holdings Limited (ASX:AGH) Reflects Market Sentiment Regarding Its Revenues
April 16, 2025 02:33 PM AEST| By Team Kalkine MediaHighlights:,Althea Group Holdings exhibits a low price-to-sales ratio, reflecting its below-industry valuation.,The company has shown positive revenue growth, though it trails behind industry growth projections.,Investor sentiment indicates cautious...
Tryptamine Therapeutics: Insider Transactions and Ownership Insights
April 05, 2025 05:31 PM AEDT| By Team Kalkine MediaHighlights,Founder William Garner makes significant stock purchase.,Insider ownership stands at 35% of the company.,Recent purchases suggest perceived long-term value.,In recent developments, William Garner, the Founder and Managing Director of Trypt...
ASX: BOE — Boss Energy Stands Out as Uranium Demand Puts ASX Producers Back in Play
June 18, 2026 02:09 PM AEST| By Aditi SarkarHighlightsBoss Energy (ASX: BOE) is a uranium producer that has become a prominent name in the ASX uranium sector.Renewed uranium demand, underpinned by support for nuclear power, has put ASX uranium producers back in play.The Honeymoon project provides Boss Energy with production-stage exposure, discussed …
Investors Remain Pessimistic About Neuren Pharmaceuticals Limited's (NEU) Outlook
April 02, 2025 07:31 PM AEDT| By Team Kalkine MediaHighlights:,Neuren Pharmaceuticals reports a price-to-earnings ratio below the broader market.,The company's earnings have shown a decline, influencing its valuation.,Market expectations indicate continued financial challenges in the coming years.,Ne...
We Don't Have Major Concerns Regarding LTR Pharma's (LTP) Cash Burn Rate
March 19, 2025 03:34 PM AEDT| By Team Kalkine MediaHighlights:,LTR Pharma maintains a strong cash position with no outstanding debt.,Recent cash burn increase attributed to operational expansion.,Future funding options include capital raising through share issuance.,The pharmaceutical sector continue...
Exploring Growth Opportunities with High Insider Ownership on the ASX
March 19, 2025 09:33 AM AEDT| By Team Kalkine MediaHighlights,ASX200's volatility highlights growth sector opportunities.,High insider ownership often signals company confidence.,Explore top companies thriving in current market scenarios.,In recent times, the ASX200 has shown variable performances ac...
ASX: EBR — EBR Systems Raises the Bar as Medtech Capital Markets Stay Tough
June 18, 2026 02:08 PM AEST| By Aditi SarkarHighlightsEBR Systems (ASX: EBR) is advancing wireless cardiac pacing technology within the implantable cardiac device sector.The company has moved to raise capital, underscoring the funding needs of commercial-stage medtech.The catalyst lands amid tough medtech capital markets, where funding access and terms are under scrutiny.Leadless, …
Syntara (ASX:SNT) shareholders have experienced remarkable returns, over the past year.
March 19, 2025 09:33 AM AEDT| By Team Kalkine MediaHighlights,SNT shares soared by an impressive 305% over the past year.,Recent financial results indicate significant revenue growth.,Long-term shareholders experienced a challenging three years.,While some investors are content with the steady approa...
Invex Therapeutics (ASX:IXC) - A Glimpse of Change
March 18, 2025 03:30 PM AEDT| By Team Kalkine MediaHighlights,Invex Therapeutics shares increased by 12% in a week,A significant decrease of 88% over three years,Total Shareholder Return (TSR) outperforms share price drop,Invex Therapeutics Ltd (,ASX:IXC,) has witnessed a 12% rise in its share price...
Avecho Biotechnology Reports Strong Revenue Growth Amid Share Price Decline
March 13, 2025 11:31 AM AEDT| By Team Kalkine MediaHighlights:,Revenue experienced a substantial increase compared to the previous fiscal period.,A decline in net loss reflects an improvement in financial performance.,Share value moved lower over the past week.,Avecho Biotechnology (ASX:AVE) , operat...
Should You Keep Grandbridge (ASX:GBA) on Watchlists
June 18, 2026 12:07 PM AEST| By Sonal GoyalGrandbridge Limited (ASX:GBA) has become one of the more-discussed ASX small-caps in recent trading sessions, with rising trader attention turning the spotlight back onto this Australian investment and corporate advisory company. As a small-cap stock with exposure to a portfolio of unlisted and listed …
ECS Botanics Holdings (ASX:ECS): A Deeper Dive into the P/S Ratio
March 11, 2025 07:30 PM AEDT| By Team Kalkine MediaHighlights,ECS Botanics Holdings (ASX:ECS) displays a low price-to-sales (P/S) ratio.,Investors show concerns over declining revenue trends.,Potential for future growth remains uncertain amid industry comparisons.,For those eyeing the pharmaceutical...
Island Pharmaceuticals (ASX:ILA): Managing Cash Flow in a Growth Stage
March 03, 2025 05:31 PM AEDT| By Team Kalkine MediaHighlights:,Island Pharmaceuticals' share price surged significantly in the past year.,The company holds AU$4 million in cash, with no debt, offering a 17-month cash runway.,The company's modest cash burn rate aligns with its market capitalisation an...
Vitura Health (ASX:VIT) Reports Decline in Profit Margins Amid Revenue Growth
March 03, 2025 05:31 PM AEDT| By Team Kalkine MediaHighlights:,Vitura Health’s revenue grew by 4.5% in the first half of 2025.,Net income decreased significantly, reflecting a drop in profit margins.,Shares saw a sharp decline over the past week.,Vitura Health,(ASX:VIT),operates within the healthcare...
DigitalX (ASX:DCC) Edges Up as Bitcoin-Treasury Play Holds Investor Attention
June 18, 2026 11:46 AM AEST| By Sonal GoyalDigitalX Limited (ASX:DCC) has continued to draw attention from ASX investors as the small-cap fintech leans further into its digital-assets strategy and its position as one of the Australian stock market’s most prominent Bitcoin-treasury names. The technology stock pairs a digital-asset funds management business …
Moderate Expansion for Ecofibre Limited (ASX:EOF) Contributes to 26% Drop in Stock Price
March 01, 2025 09:30 AM AEDT| By Team Kalkine MediaHighlights:,Ecofibre's share price has experienced a significant downturn in recent months.,The company's price-to-sales ratio remains notably lower than industry standards.,Revenue growth remains a concern compared to broader sector expectations.,Ec...
Firebrick Pharma (ASX:FRE) First Half 2025 Financial Overview
February 25, 2025 01:33 PM AEDT| By Team Kalkine MediaHighlights,Significant revenue drop to AU$197.1k from 1H 2024.,Net loss increased by 61% from the previous year.,Shares gained a slight increase over the past week.,The financial landscape of Firebrick Pharma (ASX:FRE) for the First Half of 2025 reve...
Advertise your brand on Kalkine Media